CSI Market
Sign In | Register

Accelerate Diagnostics Inc (AXDX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access AXDX Annual Cash Flow →
Reviewing cash flow figures over time highlights how Accelerate Diagnostics Inc balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
12 Months 		(Sep 30 2024) (Jun 30 2024) (Mar 31 2024) (Dec 31 2023)
Operating Activities
Income-50.05
Depreciation & amortization3.42
Amortization of Other Assets8.68
Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.35
Increase (Decrease) in Inventories-0.05
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.20
Share-based Compensation4.38
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest4.38
Deferred Compensation Arrangement With Individual Contributions By Employer-
Deferred Compensation Contributions-
Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost-
Amortization Of Debt Issuance Costs Related Party-
Increase Decrease Related Party Accrued Interest-
Increase Decrease In Contract With Customer Liability0.47
Gain Loss On Fair Value Adjustment5.41
Stock Issued0.04
Sale Of Stock Issuance Cost0.68
Income taxes0.00
Unrealized Gain (Loss) on Investments-0.07
Increase (Decrease) in Accounts Receivable0.44
Increase (Decrease) in Accounts Payable0.79
Accrued Expense-0.95
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.10
Other Working Capital0.00
Other Noncash Expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.74
Discontinued operations0.00
Net Cash flow from Operating Activities-24.19
Investing Activities
Capital Expenditures-0.51
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition-
Available For Sale Securities Gross Realized Gains Losses Sale Proceeds-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.51
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.77
Long-term debt - borrowings14.27
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock9.52
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net4.75
Proceeds from Stock Options and Warrants Exercised-
Proceeds From Recovery of Related Party Short Swing Profits-
Finance Lease Principal Payments-0.68
Payments Of Debt Conversion Costs-
Proceeds From Issuance Of Common And Preferred Stock Net-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities27.05
Effect of exchange rate on cash flow0.61
Discontinued operations0.00
Free Cash Flow-24.70
Total Cash Flow2.96
4 historic quarters locked

Sign in to unlock the full Accelerate Diagnostics Inc cash flow history.

Sign In Create Free Account

About Accelerate Diagnostics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-24-046408

Figures are derived from filed reports and may be restated. Historical data is subject to revision.